Medicament for treating chronic hepatitis

A chronic hepatitis and drug technology, applied in the processing and preparation of traditional Chinese medicine, can solve the problems of unsatisfactory curative effect, inconvenience of body and life, neglect of anti-fibrosis, etc., to improve liver function, reduce treatment cost, and achieve good treatment effect Effect

Inactive Publication Date: 2010-06-16
王宏钊
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Chronic hepatitis is a common disease. There are many reasons for hepatitis, including genetics, environment, diet, drugs, viral infections, etc., as well as smoking, excessive alcoholism, and excessive fatigue. great inconvenience
[0003] At present, although there are many drugs for the treatment of chronic hepatitis, most of them focus on antiviral therapy and ignore the appropriateness of anti-fibrosis therapy. Moreover, the imported western medicines are not only expensive, but also have unsatisfactory curative effects, and have certain toxic and side effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Embodiment 1: A medicine for treating chronic hepatitis, containing the following components in parts by weight: 30-60 parts of Polygonum multiflorum, 20-50 parts of Glycyrrhiza licorice, 20-50 parts of Schisandra chinensis, 30-60 parts of Bupleurum, Angelica sinensis 30-100 parts, 30-60 parts of astragalus, 40-60 parts of desmodium, 20-40 parts of woody fragrance, 20-90 parts of hawthorn, 25-75 parts of honeysuckle, 30-45 parts of angelica, 30-70 parts of tangerine peel, honey 300-500 copies.

[0032] Dry the components except honey, grind them together, pass through a 100-mesh sieve, and mix thoroughly; then add honey, add water and stir evenly according to the actual situation, and make the required pharmaceutical formulation, or Tablets, or pills, or granules, or capsules.

Embodiment 2

[0033] Example 2: The preparation method of the medicine in this example is the same as in Example 1, and the similarities will not be repeated. The differences are: 30 parts of Polygonum multiflorum, 20 parts of Radix Glycyrrhizae, 20 parts of Schisandra chinensis, 30 parts of Bupleuri, 30 parts of Angelica, Astragalus 30 parts, 40 parts of desmodium, 20 parts of woody fragrance, 20 parts of honeysuckle, 20 parts of hawthorn, 30 parts of angelica, 30 parts of tangerine peel, and 300 parts of honey.

Embodiment 3

[0034] Embodiment 3: The preparation method of the medicine of this embodiment is the same as that of Example 1, and the similarities will not be repeated. The difference is that a medicine for treating chronic hepatitis contains the following components in parts by weight: Radix Polygoni Multiflori 60 50 parts of licorice, 50 parts of schisandra, 60 parts of Bupleurum, 100 parts of angelica, 60 parts of astragalus, 60 parts of money grass, 40 parts of woody grass, 90 parts of hawthorn, 75 parts of honeysuckle, 45 parts of angelica, 70 parts of tangerine peel, honey 500 copies.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicament for treating chronic hepatitis, which comprises the following components in part by weight: 30 to 60 parts of tuber fleeceflower root, 20 to 50 parts of liquoric root, 20 to 50 parts of shizandra berry, 30 to 60 parts of Chinese thorowax root, 30 to 100 parts of Chinese angelica, 30 to 60 parts of astragalus, 40 to 60 parts of longhairy antenoron herb, 20 to 40 parts of costustoot, 20 to 90 parts of hawthorn fruit, 25 to 75 parts of honeysuckle, 30 to 70 parts of tangerine peel and 300 to 500 parts of honey. Based on Chinese medicinal and pharmacologic theory, through years of clinical practice, the medicament for treating the chronic hepatitis is prepared from pure Chinese medicaments which are selected from Chinese medical treasury and have the effects of clearing away heat and toxic materials and eliminating stagnation and removing blood stasis, can improve liver function and relieve hepatic fibrosis, has the good treatment effect on various kinds of chronic hepatitis, and also has the good treatment effect on early liver cirrhosis ascites.

Description

1. Technical field: [0001] The invention relates to a medicine, in particular to a Chinese herbal medicine for treating chronic hepatitis, and belongs to the field of processing and preparation of traditional Chinese medicines. 2. Background technology: [0002] Chronic hepatitis is a common disease. There are many reasons for hepatitis, including genetics, environment, diet, drugs, viral infections, etc., as well as smoking, excessive drinking, and excessive fatigue. Great inconvenience. [0003] At present, although there are many drugs for the treatment of chronic hepatitis, most of them focus on antiviral therapy and neglect the treatment of anti-fibrosis. Moreover, imported western medicines are not only expensive, but also have unsatisfactory curative effects, and have certain toxic and side effects. Therefore, people desire to have a medicine for the treatment of chronic hepatitis with low cost, easy to take, and better therapeutic effect. 3. Contents of the invent...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/752A61K9/16A61K9/20A61K9/48A61P1/16A61P31/14A61P31/20
Inventor 王宏钊
Owner 王宏钊
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap